Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice

In conclusion, anti-GPC3 produced anti-tumor effects against skin cancer, which can be explained by reduction in both inflammatory and apoptotic pathways. Targeting GPC3 is a promising therapeutic approach for skin cancer.Graphic abstract

http://link.springer.com/10.1007/s00403-020-02102-0

Source: Archives of Dermatological Research - July 6, 2020 Category: Dermatology Source Type: research